Related Experiment Video
Updated: Feb 11, 2026

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
Published on: March 20, 2020
CD44 directed nanomicellar payload delivery platform for selective anticancer effect and tumor specific imaging of
Zhaoxian Wang1, Samaresh Sau1, Hashem O Alsaab1
1Use-inspired Biomaterials & Integrated Nano Delivery (U-BiND) Systems Laboratory Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI, USA.
Abstract:
Triple negative breast cancer (TNBC) is a highly aggressive tumor subtype, lacking estrogen, progesterone and human epidermal growth factor-2 (HER-2) receptors. Thus, early detection and targeted therapy of TNBC is an urgent need. Herein, we have developed a CD44 targeting Hyaluronic Acid (HA) decorated biocompatible oligomer, containing FDA approved vitamin E TPGS and Styrene Maleic Anhydride (SMA) (HA-SMA-TPGS) for targeting TNBC. The self-assembling HA-SMA-TPGS was encapsulated with poorly water soluble, potent curcumin analogue (CDF) to form nanomicelles (NM), HA-SMA-TPGS-CDF has demonstrated excellent nanoparticle characteristics for parenteral delivery. The targeted NM can selectively kill TNBC cells through CD44 mediated apoptosis pathway. Tumor imaging using phase-2 clinical trial near infrared (NIR)-fluorescent dye (S0456) conjugate, HA-SMA-TPGS-S0456 showed excellent TNBC tumor accumulation with minimum liver and spleen uptake. To our best of knowledge, for the first time, we are reporting a promising platform for CD44 mediated multimodal NIR imaging and cytotoxin delivery to TNBC.
Insights
Researchers developed a novel nanoparticle for triple-negative breast cancer (TNBC) that targets CD44 receptors. This targeted therapy platform combines imaging and drug delivery for effective TNBC treatment.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Oncology
Background:
- Triple-negative breast cancer (TNBC) is aggressive and lacks targeted therapy options.
- Early detection and effective treatment of TNBC remain critical challenges.
- CD44 receptor is a promising target for TNBC therapy.
Purpose of the Study:
- To develop a CD44-targeted nanomicelle (NM) platform for multimodal imaging and therapy of TNBC.
- To encapsulate a potent curcumin analogue (CDF) within the NM for targeted drug delivery.
- To evaluate the efficacy of the NM for TNBC cell targeting, apoptosis induction, and in vivo tumor imaging.
Main Methods:
- Fabrication of Hyaluronic Acid (HA)-decorated Styrene Maleic Anhydride (SMA) and Vitamin E TPGS (HA-SMA-TPGS) oligomers.
- Self-assembly of HA-SMA-TPGS into nanomicelles encapsulating curcumin analogue (CDF).
- In vitro evaluation of CD44-mediated targeting and apoptosis induction in TNBC cells.
- In vivo tumor imaging using a near-infrared (NIR) fluorescent dye (S0456) conjugate.
Main Results:
- HA-SMA-TPGS-CDF nanomicelles exhibited excellent characteristics for parenteral delivery.
- Targeted nanomicelles selectively induced apoptosis in CD44-positive TNBC cells.
- In vivo imaging demonstrated significant TNBC tumor accumulation of HA-SMA-TPGS-S0456 with minimal off-target organ uptake.
Conclusions:
- The developed HA-SMA-TPGS-CDF nanomicelles represent a promising platform for CD44-mediated targeted therapy of TNBC.
- This platform enables simultaneous near-infrared fluorescence imaging and cytotoxic drug delivery.
- This multimodal approach offers a novel strategy for advancing TNBC diagnosis and treatment.
Related Concept Videos
Dose-Response Relationship: Selectivity and Specificity
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Scalar and Vector Triple Products
The scalar triple product is the dot product of a vector with the cross product of two vectors....
Negative Regulator Molecules
Positive, Negative, and Zero Work
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

